---
document_datetime: 2025-12-02 05:27:30
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/staquis.html
document_name: staquis.html
version: success
processing_time: 0.110643
conversion_datetime: 2025-12-24 20:06:27.557136
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Staquis

[RSS](/en/individual-human-medicine.xml/67290)

##### Withdrawn

This medicine's authorisation has been withdrawn

crisaborole Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Staquis](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 31 January 2022, the European Commission withdrew the marketing authorisation for Staquis (crisaborole) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Pfizer Europe MA EEIG, which notified the European Commission of its decision not to market the product in the EU for commercial reasons.

Staquis was granted marketing authorisation in the EU on 27 March 2020 for the treatment of mild to moderate atopic dermatitis. The marketing authorisation was initially valid for a 5-year period. The product had not been marketed in the EU.

The European Public Assessment Report (EPAR) for Staquis is updated to indicate that the marketing authorisation is no longer valid.

Staquis : EPAR - Medicine overview

Reference Number: EMA/64649/2020

English (EN) (283.45 KB - PDF)

**First published:** 22/04/2020

**Last updated:** 08/02/2022

[View](/en/documents/overview/staquis-epar-medicine-overview_en.pdf)

[Other languages (22)](#file-language-dropdown-640)

български (BG) (328.69 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/bg/documents/overview/staquis-epar-medicine-overview_bg.pdf)

español (ES) (281.81 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/es/documents/overview/staquis-epar-medicine-overview_es.pdf)

čeština (CS) (320.82 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/cs/documents/overview/staquis-epar-medicine-overview_cs.pdf)

dansk (DA) (281.27 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/da/documents/overview/staquis-epar-medicine-overview_da.pdf)

Deutsch (DE) (285.3 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/de/documents/overview/staquis-epar-medicine-overview_de.pdf)

eesti keel (ET) (270.41 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/et/documents/overview/staquis-epar-medicine-overview_et.pdf)

ελληνικά (EL) (329.52 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/el/documents/overview/staquis-epar-medicine-overview_el.pdf)

français (FR) (283.57 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/fr/documents/overview/staquis-epar-medicine-overview_fr.pdf)

hrvatski (HR) (303.39 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/hr/documents/overview/staquis-epar-medicine-overview_hr.pdf)

italiano (IT) (280.3 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/it/documents/overview/staquis-epar-medicine-overview_it.pdf)

latviešu valoda (LV) (329.73 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/lv/documents/overview/staquis-epar-medicine-overview_lv.pdf)

lietuvių kalba (LT) (305.64 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/lt/documents/overview/staquis-epar-medicine-overview_lt.pdf)

magyar (HU) (318.99 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/hu/documents/overview/staquis-epar-medicine-overview_hu.pdf)

Malti (MT) (320.18 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/mt/documents/overview/staquis-epar-medicine-overview_mt.pdf)

Nederlands (NL) (282.3 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/nl/documents/overview/staquis-epar-medicine-overview_nl.pdf)

polski (PL) (321.05 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/pl/documents/overview/staquis-epar-medicine-overview_pl.pdf)

português (PT) (283.06 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/pt/documents/overview/staquis-epar-medicine-overview_pt.pdf)

română (RO) (303.92 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/ro/documents/overview/staquis-epar-medicine-overview_ro.pdf)

slovenčina (SK) (319.54 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/sk/documents/overview/staquis-epar-medicine-overview_sk.pdf)

slovenščina (SL) (317.49 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/sl/documents/overview/staquis-epar-medicine-overview_sl.pdf)

Suomi (FI) (279.2 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/fi/documents/overview/staquis-epar-medicine-overview_fi.pdf)

svenska (SV) (281.27 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/sv/documents/overview/staquis-epar-medicine-overview_sv.pdf)

Staquis : EPAR - Risk-management-plan summary

English (EN) (221.92 KB - PDF)

**First published:** 22/04/2020

**Last updated:** 08/02/2022

[View](/en/documents/rmp-summary/staquis-epar-risk-management-plan-summary_en.pdf)

## Product information

Staquis : EPAR - Product Information

English (EN) (824.49 KB - PDF)

**First published:** 22/04/2020

**Last updated:** 08/02/2022

[View](/en/documents/product-information/staquis-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-58)

български (BG) (1.77 MB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/bg/documents/product-information/staquis-epar-product-information_bg.pdf)

español (ES) (652.9 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/es/documents/product-information/staquis-epar-product-information_es.pdf)

čeština (CS) (854.6 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/cs/documents/product-information/staquis-epar-product-information_cs.pdf)

dansk (DA) (701.91 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/da/documents/product-information/staquis-epar-product-information_da.pdf)

Deutsch (DE) (631.59 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/de/documents/product-information/staquis-epar-product-information_de.pdf)

eesti keel (ET) (632.47 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/et/documents/product-information/staquis-epar-product-information_et.pdf)

ελληνικά (EL) (1.11 MB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/el/documents/product-information/staquis-epar-product-information_el.pdf)

français (FR) (646.88 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/fr/documents/product-information/staquis-epar-product-information_fr.pdf)

hrvatski (HR) (686.34 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/hr/documents/product-information/staquis-epar-product-information_hr.pdf)

íslenska (IS) (603.78 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/is/documents/product-information/staquis-epar-product-information_is.pdf)

italiano (IT) (654.17 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/it/documents/product-information/staquis-epar-product-information_it.pdf)

latviešu valoda (LV) (954.3 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/lv/documents/product-information/staquis-epar-product-information_lv.pdf)

lietuvių kalba (LT) (666.03 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/lt/documents/product-information/staquis-epar-product-information_lt.pdf)

magyar (HU) (907.86 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/hu/documents/product-information/staquis-epar-product-information_hu.pdf)

Malti (MT) (990.45 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/mt/documents/product-information/staquis-epar-product-information_mt.pdf)

Nederlands (NL) (743.33 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/nl/documents/product-information/staquis-epar-product-information_nl.pdf)

norsk (NO) (599.01 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/no/documents/product-information/staquis-epar-product-information_no.pdf)

polski (PL) (844.03 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/pl/documents/product-information/staquis-epar-product-information_pl.pdf)

português (PT) (718.77 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/pt/documents/product-information/staquis-epar-product-information_pt.pdf)

română (RO) (764.23 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/ro/documents/product-information/staquis-epar-product-information_ro.pdf)

slovenčina (SK) (932.49 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/sk/documents/product-information/staquis-epar-product-information_sk.pdf)

slovenščina (SL) (945.75 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/sl/documents/product-information/staquis-epar-product-information_sl.pdf)

Suomi (FI) (699.75 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/fi/documents/product-information/staquis-epar-product-information_fi.pdf)

svenska (SV) (617.55 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/sv/documents/product-information/staquis-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** N/0006 01/10/2021

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Staquis : EPAR - All Authorised presentations

English (EN) (195.86 KB - PDF)

**First published:** 22/04/2020

**Last updated:** 08/02/2022

[View](/en/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-403)

български (BG) (201.75 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/bg/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_bg.pdf)

español (ES) (186.74 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/es/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_es.pdf)

čeština (CS) (195.66 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/cs/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (187.51 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/da/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (188.07 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/de/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (186.99 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/et/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (201.24 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/el/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_el.pdf)

français (FR) (187.58 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/fr/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (186.48 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/hr/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (187.47 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/is/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_is.pdf)

italiano (IT) (186.31 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/it/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (195.58 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/lv/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (187.21 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/lt/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (195.07 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/hu/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (199.97 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/mt/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (186.56 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/nl/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (191.95 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/no/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_no.pdf)

polski (PL) (195.15 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/pl/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_pl.pdf)

português (PT) (186.88 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/pt/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_pt.pdf)

română (RO) (186.68 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/ro/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (195.31 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/sk/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (193.6 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/sl/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (186.56 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/fi/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (186.08 KB - PDF)

**First published:**

22/04/2020

**Last updated:**

08/02/2022

[View](/sv/documents/all-authorised-presentations/staquis-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Staquis Active substance Crisaborole International non-proprietary name (INN) or common name crisaborole Therapeutic area (MeSH) Dermatitis, Atopic Anatomical therapeutic chemical (ATC) code D11AH06

### Pharmacotherapeutic group

Other dermatological preparations

### Therapeutic indication

Staquis is indicated for treatment of mild to moderate atopic dermatitis in adults and paediatric patients from 2 years of age with ? 40% body surface area (BSA) affected.

## Authorisation details

EMA product number EMEA/H/C/004863 Marketing authorisation holder

Pfizer Europe MA EEIG

Boulevard de la Plaine 17

Opinion adopted 30/01/2020 Marketing authorisation issued 27/03/2020 Revision 6

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Staquis : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (648.05 KB - PDF)

**First published:** 23/03/2021

**Last updated:** 08/02/2022

[View](/en/documents/procedural-steps-after/staquis-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Staquis-H-C-4863-P46-006: EPAR - Assessment report

Adopted

Reference Number: EMA/717595/2021

English (EN) (4.25 MB - PDF)

**First published:** 22/12/2021

**Last updated:** 08/02/2022

[View](/en/documents/variation-report/staquis-h-c-4863-p46-006-epar-assessment-report_en.pdf)

Staquis-H-C-4863-P46-005: EPAR - Assessment report

Adopted

Reference Number: EMA/702062/2021

English (EN) (1.64 MB - PDF)

**First published:** 13/12/2021

**Last updated:** 08/02/2022

[View](/en/documents/variation-report/staquis-h-c-4863-p46-005-epar-assessment-report_en.pdf)

Staquis-H-C-4863-P46-002 : EPAR - Assessment report

Adopted

Reference Number: EMA/662601/2021

English (EN) (3.8 MB - PDF)

**First published:** 25/03/2021

**Last updated:** 08/02/2022

[View](/en/documents/variation-report/staquis-h-c-4863-p46-002-epar-assessment-report_en.pdf)

Staquis-H-C-4863-P46-003 : EPAR - Assessment report

Adopted

Reference Number: EMA/591235/2020

English (EN) (2.89 MB - PDF)

**First published:** 05/11/2020

**Last updated:** 08/02/2022

[View](/en/documents/variation-report/staquis-h-c-4863-p46-003-epar-assessment-report_en.pdf)

## Initial marketing authorisation documents

Staquis : EPAR - Public assessment report

Adopted

Reference Number: EMA/88816/2020

English (EN) (7.86 MB - PDF)

**First published:** 22/04/2020

**Last updated:** 08/02/2022

[View](/en/documents/assessment-report/staquis-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Staquis

Adopted

Reference Number: EMA/CHMP/35206/2020

English (EN) (714.59 KB - PDF)

**First published:** 31/01/2020

**Last updated:** 08/02/2022

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-staquis_en.pdf)

#### News on Staquis

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27-30 January 2020](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-27-30-january-2020) 31/01/2020

**This page was last updated on** 08/02/2022

## Share this page

[Back to top](#main-content)